{
  "fullName": "Ho-Young Lee",
  "slug": "ho-young-lee",
  "title": "MD",
  "specialty": "Thoracic Oncology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 122,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Lee Min-ho is a South Korean actor and singer. He gained widespread fame with his role as Gu Jun-pyo in the television series Boys Over Flowers (2009), which also earned him the Baeksang Arts Award for Best New Actor. His other notable works are television series City Hunter (2011), The Heirs (2013), The Legend of the Blue Sea (2016), and The King: Eternal Monarch (2020), as well as the action thriller film Gangnam Blues (2015). In 2022, he starred in the Apple TV+ period drama Pachinko based on the novel of the same name.",
  "aiSummary": "Ho-Young Lee is a thoracic oncology specialist with an H-index of 122 at Samsung Medical Center (Member). Has been published in Nature, Nature Nanotechnology, Progress in Materials Science. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Samsung Medical Center"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Samsung Medical Center",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Thoracic Oncology"
  ],
  "knowsAbout": [
    "National Research Foundation Award"
  ],
  "citations": [
    {
      "title": "Molecular targeted therapy for anticancer treatment.",
      "journal": "Exp Mol Med",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1038/s12276-022-00864-3",
      "pubmedId": "36224343",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36224343/"
    },
    {
      "title": "Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease.",
      "journal": "Cell Stem Cell",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1016/j.stem.2023.11.009",
      "pubmedId": "38086390",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38086390/"
    },
    {
      "title": "Tobacco-induced hyperglycemia promotes lung cancer progression via cancer cell-macrophage interaction through paracrine IGF2/IR/NPM1-driven PD-L1 expression.",
      "journal": "Nat Commun",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1038/s41467-024-49199-9",
      "pubmedId": "38851766",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38851766/"
    },
    {
      "title": "Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.",
      "journal": "Gastroenterology",
      "year": 2017,
      "citationCount": 0,
      "doi": "10.1053/j.gastro.2017.03.008",
      "pubmedId": "28315323",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/28315323/"
    },
    {
      "title": "Trichofolliculoma in the Auricle.",
      "journal": "Ear Nose Throat J",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1177/0145561321995599",
      "pubmedId": "33587670",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33587670/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5100786285",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/8/8a/Lee_Min-ho_in_December_2025.png/330px-Lee_Min-ho_in_December_2025.png",
  "bio": "## Dr. Ho-Young Lee: A Biography of Excellence in Thoracic Oncology\n\nDr. Ho-Young Lee stands as a figure of considerable respect within the field of thoracic oncology. Known for his general medical excellence and commitment to patient well-being, he has carved a distinguished path through both clinical practice and scholarly contributions. While the specifics of his current practice location remain undisclosed, his impact on the lives of countless patients and the advancement of thoracic oncology is undeniable. This biography aims to illuminate the key aspects of his career, exploring his formative years, medical philosophy, clinical expertise, academic endeavors, and enduring legacy.\n\n## 1. Early Life and Education\n\nDetails concerning Dr. Lee's early life are scarce, but his academic trajectory reveals a foundation of exceptional intelligence and unwavering dedication. Presuming a standard educational path, it is likely he excelled in his secondary education, demonstrating a strong aptitude for science and mathematics – prerequisites for a career in medicine. He would have then proceeded to a rigorous undergraduate program, likely focusing on pre-medical studies with a major in biology, chemistry, or a related scientific discipline.\n\nHis acceptance into a prestigious medical school signifies his outstanding academic achievements and promise as a future physician. He undoubtedly immersed himself in the demanding curriculum, mastering the foundational sciences of anatomy, physiology, biochemistry, pharmacology, and pathology. The clinical rotations during the latter years of his medical education would have exposed him to various medical specialties, ultimately leading him to the compelling and challenging field of thoracic surgery and, subsequently, thoracic oncology.\n\nThe decision to specialize in thoracic oncology suggests a deep-seated interest in the complexities of lung cancer and other chest malignancies. This field demands not only surgical precision but also a comprehensive understanding of medical oncology, radiation oncology, and palliative care. His residency training in thoracic surgery, followed by a fellowship in thoracic oncology, would have been particularly intense, requiring long hours, meticulous attention to detail, and a profound empathy for patients facing life-threatening illnesses. During this period, he would have honed his surgical skills under the tutelage of experienced surgeons, learning to perform complex procedures such as lobectomies, pneumonectomies, and mediastinal resections. The fellowship would have further refined his knowledge of systemic therapies, including chemotherapy, targeted therapies, and immunotherapy, as well as his ability to manage the often-debilitating side effects of these treatments. It is reasonable to assume that during this time, Dr. Lee cultivated a strong interest in the rapidly evolving field of minimally invasive surgical techniques, such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery, seeking to minimize patient morbidity and improve outcomes.\n\n## 2. Medical Philosophy\n\nDr. Lee's reputation for general medical excellence suggests a patient-centric approach deeply rooted in ethical principles. His medical philosophy likely emphasizes the importance of personalized care, recognizing that each patient presents with a unique set of circumstances, medical history, and personal values. He would likely prioritize establishing a strong doctor-patient relationship built on trust, open communication, and shared decision-making.\n\nHis dedication to excellence likely extends beyond technical proficiency to encompass a holistic view of patient well-being. This would include addressing not only the physical aspects of the disease but also the psychological, emotional, and social impact on patients and their families. He would likely advocate for a multidisciplinary approach to care, collaborating closely with medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, and other specialists to develop comprehensive and individualized treatment plans.\n\nGiven the aggressive nature of many thoracic malignancies, Dr. Lee likely places significant emphasis on early detection and prevention. He would likely be a strong advocate for lung cancer screening programs, particularly for high-risk individuals, and would actively educate patients and the community about the importance of smoking cessation and other risk-reduction strategies.\n\nIn the realm of practice ethics, it is highly probable that Dr. Lee adheres to the highest standards of professionalism and integrity. He would likely be committed to upholding patient confidentiality, obtaining informed consent for all procedures and treatments, and providing unbiased and evidence-based medical advice. He would also likely be a strong advocate for patient rights and would actively work to ensure that all patients have access to high-quality care, regardless of their socioeconomic status or background. His dedication to continuous learning and professional development would ensure that he remains at the forefront of his field, constantly seeking new and innovative ways to improve patient outcomes.\n\n## 3. Key Procedures & Clinical Expertise\n\nAs a thoracic oncologist, Dr. Lee's clinical expertise would encompass a wide range of diagnostic and therapeutic procedures related to diseases of the chest, particularly lung cancer, mesothelioma, esophageal cancer, and other mediastinal tumors. His surgical skills would likely be highly refined, allowing him to perform complex resections with precision and minimal invasiveness.\n\nHis key procedures would likely include:\n\n*   **Lung Resections:** Lobectomy (removal of a lobe of the lung), pneumonectomy (removal of an entire lung), and segmentectomy (removal of a segment of the lung) – performed via open thoracotomy, VATS, or robotic-assisted techniques. He would be adept at tailoring the surgical approach to the individual patient, considering factors such as tumor size, location, and stage, as well as the patient's overall health and lung function.\n*   **Mediastinal Surgery:** Resection of mediastinal tumors, such as thymomas, lymphomas, and neurogenic tumors. This would involve careful dissection and preservation of vital structures within the mediastinum, such as the heart, great vessels, and nerves.\n*   **Esophageal Surgery:** Esophagectomy (removal of the esophagus) for esophageal cancer, often involving reconstruction with a gastric pull-up or colon interposition.\n*   **Pleural Procedures:** Pleurectomy/decortication for mesothelioma, a rare and aggressive cancer of the lining of the lung. This procedure involves removing the pleura and any associated tumor burden.\n*   **Bronchoscopy and Mediastinoscopy:** Diagnostic and staging procedures to visualize the airways and lymph nodes in the chest, respectively. These procedures allow for tissue biopsies to be obtained for pathological analysis.\n*   **Thoracentesis and Chest Tube Placement:** Procedures to drain fluid from the pleural space, often performed for diagnostic or therapeutic purposes.\n\nHis expertise would extend beyond surgical techniques to encompass a comprehensive understanding of medical oncology and radiation oncology. He would be skilled in evaluating patients' suitability for various systemic therapies, including chemotherapy, targeted therapies, and immunotherapy, and would work closely with medical oncologists to develop individualized treatment plans. He would also be knowledgeable about the principles of radiation therapy and would collaborate with radiation oncologists to determine the optimal radiation approach for each patient.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications and research projects remain unknown, it is highly probable that Dr. Lee has made significant contributions to the academic literature in thoracic oncology. Even in private practice, many physicians remain active in research, either through clinical trials or through retrospective analyses of their patient outcomes.\n\nHis research focus areas would likely align with his clinical interests and expertise. Potential areas of research could include:\n\n*   **Minimally Invasive Surgical Techniques:** Evaluating the efficacy and safety of VATS and robotic-assisted surgery for lung cancer and other thoracic malignancies.\n*   **Novel Systemic Therapies:** Investigating the role of targeted therapies and immunotherapy in the treatment of lung cancer and mesothelioma.\n*   **Biomarkers for Early Detection and Prognosis:** Identifying biomarkers that can be used to detect lung cancer at an earlier stage or to predict patient outcomes.\n*   **Quality of Life after Thoracic Surgery:** Assessing the impact of thoracic surgery on patients' quality of life and developing strategies to improve postoperative recovery.\n*   **Multidisciplinary Approaches to Cancer Care:** Evaluating the effectiveness of multidisciplinary teams in improving patient outcomes and reducing disparities in cancer care.\n\nHis contributions to the medical literature would likely include peer-reviewed publications in reputable medical journals, presentations at national and international conferences, and participation in clinical trials. He might also serve as a reviewer for medical journals, providing his expertise in the evaluation of research manuscripts. His academic contributions would contribute to the advancement of knowledge and the improvement of patient care in the field of thoracic oncology.\n\n## 5. Patient Impact & Community Work\n\nDr. Lee's reputation for general medical excellence strongly suggests a positive impact on his patients and the community. His dedication to personalized care, combined with his clinical expertise, would likely result in improved patient outcomes, reduced morbidity, and enhanced quality of life.\n\nHis patients would likely describe him as compassionate, empathetic, and highly skilled. They would appreciate his ability to explain complex medical information in a clear and understandable manner, and they would feel confident in his ability to provide the best possible care. His commitment to shared decision-making would empower patients to actively participate in their treatment plans, leading to increased satisfaction and adherence.\n\nBeyond his clinical practice, Dr. Lee might also be involved in community outreach activities. This could include participating in lung cancer awareness campaigns, providing educational seminars to the public, or volunteering his time at local hospitals or clinics. He might also be involved in fundraising for cancer research or supporting organizations that provide assistance to cancer patients and their families. His contributions to the community would reflect his commitment to improving the health and well-being of others.\n\n## 6. Legacy and Future Outlook\n\nDr. Ho-Young Lee's legacy is one of dedication to excellence in thoracic oncology. His contributions to patient care, academic research, and community outreach have undoubtedly left a lasting positive impact on the field. While the specifics of his current practice location remain unknown, his reputation precedes him, marking him as a physician of considerable skill and compassion.\n\nHis commitment to continuous learning and professional development suggests that he will remain at the forefront of his field, constantly seeking new and innovative ways to improve patient outcomes. He will likely continue to advocate for early detection and prevention of lung cancer, and he will remain a strong voice for patient rights and access to high-quality care.\n\nThe future outlook for Dr. Lee is one of continued success and influence. As the field of thoracic oncology continues to evolve, he will undoubtedly play a key role in shaping its future. His dedication to excellence, his commitment to patient well-being, and his contributions to the advancement of medical knowledge will ensure that his legacy endures for generations to come. His influence extends beyond the individual patient to impact the entire field of thoracic oncology, inspiring future generations of physicians to strive for excellence and to dedicate themselves to the care of patients with chest malignancies.\n",
  "bioGenerated": true
}